Skip to main content
. 2018 Jun 20;27(6):1791–1799. doi: 10.1007/s10068-018-0414-1

Table 5.

Effects of oligopeptide on serum IL-2, IL-6, TNF-α, IgG, and IgM in cyclophosphamide-treated mice

Group IL-2 (pg/mL) IL-6 (pg/mL) TNF-α (ng/L) IgG (µg/mL) IgM (µg/mL)
NC 1739 ± 22.3a 79.74 ± 2.78a 595.7 ± 23.9a 382.9 ± 27.9a 50.93 ± 2.00a
CY 1653 ± 41.0b 69.46 ± 2.68b 564.5 ± 20.8a 317.4 ± 21.5b 32.32 ± 3.67b
CP-5 2101 ± 17.4a 72.25 ± 4.03b 589.5 ± 10.6a 337.8 ± 10.1a 35.20 ± 1.97b
CP-10 2106 ± 18.1a 84.56 ± 4.80a 600.0 ± 37.9a 439.1 ± 42.9c 52.53 ± 2.9a
CP-20 2047 ± 10.0a 82.53 ± 5.92a 685.8 ± 56.8b 396.9 ± 16.3ac 43.56 ± 1.64a

Different characters in each column indicate significantly different at 0.05 levels

NC normal control, CY cyclophosphamide model control, CP cottonseed meal oligopeptides were administered via gavage in mice by cyclophosphamide treated